World Congress Support Services and Hub Design Summit
On July 25th, Shishir will also lead a panel of experts from several pharma manufacturer companies focused on uncovering data strategies and best practices behind successful hubs. As pharmaceutical and biotech companies continue to advance hub design, it is important to understand the value of different design elements before making the high investments necessary to develop and maintain a hub program. There are multiple performance expectations around hub design, and it is imperative to explore the intricacies of varying elements that would ensure the program has the processes and capabilities necessary to deliver the desired patient services, while also ensuring ROI of hub services.
Maria Bucceri Kirsch
Head of Patient and Specialty Services, Strategy and Operations, Novartis
Director, Specialty Pharmacy, Patient Services, Hub Operations, formerly with Marathon Pharmaceuticals
Director, Patient Services, Orphan Business Unit, Horizon Pharma